Pharma shakeups put pressure on top brass at Amgen to perform
Columns, OpinionWith activist investor Bill Ackman pushing to buy Botox maker Allegran in a bid with upstart Valeant and restructurings under way at pharma giants GlaxoSmithKline, Eli Lilly & Co. and Novartis, it’s logical to question whether biotech giant Amgen will be next. So far the answer seems to be “not yet” — with one big Read More →
Without fishermen, region’s harbors and bistros would be poorer
Columns, OpinionFishing is really at the leading edge of the tourism culture. Just ask Ventura Harbor and Morro Bay, which have been trying to rebuild their tourism cred in part by reinvigorating their commercial fishing appeals and playing up their local seafood.
Paso Robles wine pioneer sets out in pursuit of the $100 bottle
Columns, OpinionPaso Robles winemaker Daniel Daou is pursuing the holy grail of California vintners: A cabernet sauvignon or Bordeaux that can reliably fetch $100 a bottle.
Limoneira could lead water-efficiency push in California drought
Columns, OpinionOne of the cool things about covering business in the Tri-Counties is that at least once a year we get a pretty close look at what’s happening at one of the region’s largest agribusiness holding companies. That’s because Santa Paula-based Limoneira Co., founded in 1893, happens to be a publicly traded company. The company began Read More →
After seven years, the financial crisis quietly ends for area banks
Op/Eds, Opinion“Even the pessimists were thinking three years,” Community West CEO Marty Plourd told me. “No one expected the low-interest-rate environment to last this long,”
